Product Data Sheet

Polfurmetinib

Catalog No. A36651

main product photo
Polfurmetinib is a potent MEK inhibitor that selectively targets the MEK signaling pathway. It effectively inhibits the phosphorylation of ERK1/2 at Thr202/Tyr204 in A375 melanoma cells, with an IC50 of 2 nM. This compound is primarily utilized in cancer research to investigate therapeutic strategies that disrupt the MEK/ERK signaling axis.
Chemical Information
Catalog NumA36651
M. Wt393.43
FormulaC18H20FN3O4S
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2845151-86-0
SynonymsMEK-IN-6
SMILESO=C1C=C2C(C(N(CC2)OCCO)=O)=C(N1C)NC3=CC=C(C=C3F)SC
Biological Activity
DescriptionPolfurmetinib is a potent MEK inhibitor that selectively targets the MEK signaling pathway. It effectively inhibits the phosphorylation of ERK1/2 at Thr202/Tyr204 in A375 melanoma cells, with an IC50 of 2 nM. This compound is primarily utilized in cancer research to investigate therapeutic strategies that disrupt the MEK/ERK signaling axis.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.